Zynex Inc Cash Flow Conversion Efficiency

Latest as of September 2025: 0.152x

Zynex Inc cash flow conversion efficiency. Based on the latest financial reports, Zynex Inc (ZYXI) has a cash flow conversion efficiency ratio of 0.152x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-6.31 Million) by net assets ($-41.37 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Zynex Inc (2000–2024)

Cash flow conversion efficiency of Zynex Inc from 2000 to 2024. This chart illustrates how Zynex Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Zynex Inc (ZYXI) stock price for real-time trading data and today's change.

Zynex Inc Cash Flow Conversion Ratio Explained

Zynex Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Zynex Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Zynex Inc ranked by their cash flow conversion efficiency. Also see Zynex Inc market capitalisation for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
SOLARTRON -NVDR- BA 1
F:TUU
0.054x
Electromagnetic Geoservices ASA
OL:EMGS
-0.107x
Mid Wynd International Investment Trust plc
LSE:MWY
0.002x
Techgen Metals Ltd
AU:TG1
-0.102x
Nigbas Nigde Beton Sanayi ve Ticaret AS
IS:NIBAS
-0.054x
Aminex PLC
STU:DOP
-0.014x
Foresight VCT PLC
LSE:FTV
-0.011x
ARC Funds Ltd
AU:ARC
-1.876x

Annual Cash Flow Conversion Efficiency for Zynex Inc (2000–2024)

The table below shows the annual cash flow conversion efficiency of Zynex Inc from 2000 to 2024. Review how much free cash does Zynex Inc generate to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 $35.71 Million $12.72 Million 0.356x -7.45%
2023-12-31 $46.13 Million $17.76 Million 0.385x +85.82%
2022-12-31 $66.36 Million $13.75 Million 0.207x +120.37%
2021-12-31 $73.92 Million $6.95 Million 0.094x +553.35%
2020-12-31 $56.85 Million $818.00K 0.014x -95.51%
2019-12-31 $19.65 Million $6.30 Million 0.321x -68.30%
2018-12-31 $9.30 Million $9.41 Million 1.012x -39.95%
2017-12-31 $4.90 Million $8.26 Million 1.685x +476.85%
2016-12-31 $-3.80 Million $1.70 Million -0.447x -433.81%
2015-12-31 $-4.07 Million $341.00K -0.084x +88.96%
2014-12-31 $-1.27 Million $961.00K -0.758x -862.60%
2013-12-31 $4.85 Million $-382.00K -0.079x -8.06%
2012-12-31 $12.05 Million $-879.00K -0.073x -104.24%
2011-12-31 $10.14 Million $-362.00K -0.036x +56.08%
2010-12-31 $8.18 Million $-665.00K -0.081x -116.68%
2009-12-31 $7.49 Million $3.65 Million 0.487x +425.29%
2008-12-31 $4.77 Million $-715.16K -0.150x -172.56%
2007-12-31 $3.62 Million $746.86K 0.206x +154.98%
2006-12-31 $1.29 Million $-483.46K -0.376x +23.75%
2005-12-31 $440.77K $-217.06K -0.492x +90.58%
2004-12-31 $202.89K $-1.06 Million -5.229x -25607.87%
2003-12-31 $-461.11K $-9.45K 0.021x -98.71%
2000-12-31 $-594.94K $-945.18K 1.589x --

About Zynex Inc

NASDAQ:ZYXI USA Medical Distribution
Market Cap
$2.61 Million
Market Cap Rank
#29703 Global
#6066 in USA
Share Price
$0.09
Change (1 day)
+7.50%
52-Week Range
$0.03 - $1.59
All Time High
$25.72
About

Zynex, Inc., together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain, and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) dev… Read more